 |
|
Release of new guidelines on the management of arterial hypertension
June 14, 2007Sophia Antipolis, France: The European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) have released new Guidelines on the management of Arterial Hypertension, which can be found in the European Heart Journal, the official journal of the ESC and Europe's leading cardiology journal.
Arterial hypertension is a causal and modifiable risk factor for cardiovascular and renal diseases and an important and frequently encountered condition in Europe. The peer-reviewed Guidelines offer up to date information on best practices and provide practical recommendations on the diagnosis, assessment and treatment of arterial hypertension.
"This update is timely given the advances made in our scientific knowledge and the unacceptable gap that still exist between what is recommended and what is achieved in daily practice regarding detection and control of arterial hypertension," said Prof. Guy De Backer, who co-chaired with Prof. Giuseppe Mancia the Task force that produced these guidelines
The update of the 2003 guidelines is based on an extensive and critical review of data from large randomized clinical trials but also on observational studies and other sources of information provided they were obtained in studies meeting a high scientific standard. The full text is accompanied by a series of boxes, figures and tables where specific recommendations are given. A more concise set of practice recommendations on the subject will become available as pocket guidelines
The updated guidelines are also meant to compliment information provided by the Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice in the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice that will be released at the annual ESC Congress in Vienna 2007.
"Guidelines are primarily educational and not prescriptive or coercive," said Prof. De Backer. "The guidelines provide a framework that can be adapted and/or adopted by national Joint Task Forces taking into account national socioeconomic and cultural factors."
European Society of Cardiology
The update of the 2003 guidelines is based on an extensive and critical review of data from large randomized clinical trials but also on observational studies and other sources of information provided they were obtained in studies meeting a high scientific standard. The full text is accompanied by a series of boxes, figures and tables where specific recommendations are given. A more concise set of practice recommendations on the subject will become available as pocket guidelines
The updated guidelines are also meant to compliment information provided by the Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice in the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice that will be released at the annual ESC Congress in Vienna 2007.
"Guidelines are primarily educational and not prescriptive or coercive," said Prof. De Backer. "The guidelines provide a framework that can be adapted and/or adopted by national Joint Task Forces taking into account national socioeconomic and cultural factors."
European Society of Cardiology
Arterial Hypertension Current Events and Arterial Hypertension News RSSUC San Diego researchers reverse pulmonary arterial hypertension in mouse models
Researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice.
Endothelin-Related Drugs Benefit Patients With Pulmonary Hypertension
Recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of pulmonary arterial hypertension and provides hope for treating other chronic diseases.
Serum sodium predicts mortality 10 times higher in PAH patients
Patients with pulmonary arterial hypertension (PAH)-chronically high blood pressure in the blood vessels of the lungs-whose serum sodium levels are low (called hyponatremia, or HN) have a very poor chance of survival and a high rate of right-heart failure (RHF), according to new research from the University of Pennsylvania.
Heart failure treated 'in the brain'
Beta-blockers heal the heart via the brain when administered during heart failure, according to a new study by UCL (University College London).
A type of antioxidant may not be as safe as once thought
Certain preparations taken to enhance athletic performance or stave off disease contain an anti-oxidant that could cause harm.
Scleroderma Outlook Improves as Survival Increases
Individuals with scleroderma are living significantly longer today, compared with 30 years ago, and the physicians who treat this rare disease of connective tissue hope the newer drugs now on the market may extend lives even further.
Obese heart attack patients are more likely to survive after treatment than normal weight patients
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal.
Pulmonary hypertension patients improve from combination therapy
For patients with pulmonary arterial hypertension (PAH), adding inhaled iloprost to treatment with bosentan-two different classes of drugs often used individually to treat PAH-increases exercise capability, reduces clinical deterioration and, in some cases, improves diagnostic functional class by one stage.
A simple, noninvasive test measures survival time in adult pulmonary hypertension
Researchers have developed a simple, noninvasive way to measure right ventricular function in the heart to predict survival of adults who suffer from pulmonary hypertension.
Pulmonary hypertension discriminates by race, gender
African-American women have the highest mortality rate for idiopathic pulmonary arterial hypertension (IPAH), according to new research.
More Arterial Hypertension Current Events and Arterial Hypertension News Articles
 |
Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide by Robert P. Baughman (Editor), Roberto G. Carbone (Editor), Giovanni Bottino (Editor) Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guide, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the first part provides and update on general issues and introduces both interstitial lung disease and associated pulmonary hypertension. A detailed analysis of the pathology of the various interstitial lung diseases is also provided. The second part addresses specific categories of disease. Bronchiolitis, hypersensitivity pneumonitis, and other conditions are covered, and the use of inspiratory and... |
|
Nadcisnienie Tetnicze = Arterial Hypertension by Foreign Trd Enterpr Ars Polona | |
 |
Omron Manual Inflation Blood Pressure Monitor by Omron This easy-to-use monitor makes it simple to measure your blood pressure at home. Just turn on the power and squeeze the inflation bulb to fill the cuff with air. The cuff deflates automatically and your measurements appear on the clear digital display. CLOSEOUT PRICE, ONLY ONE LEFT! Order now. |
 |
Pulmonary Arterial Hypertension: Pocketbook by Stewart Simon (Author) This pocketbook is a concise summary of latest evidence-based information on the diagnosis, assessment and treatment of pulmonary arterial hypertension. Dr Simon Stewart is one of the world's leading nursing experts on cardiac disease, especially heart failure. Highly illustrated, clearly and succinctly written, the book provides an introduction to pulmonary arterial hypertension. It contains clear guidelines for the effective treatment of pulmonary arterial hypertension and emphasizes the need for screening of high-risk patients and outlines the range and effectiveness of treatment options once PAH has been diagnosed. |
 |
Preventing Ischemic Events: Advances in Antiplatelet Therapy (NCME Video 733) Also With: Network For Continuing Medical Education (Primary Contributor), Alan T. Hirsch (Primary Contributor), Eric C. Ras (Primary Contributor), Eric J. Topol (Primary Contributor) Atherosclerosis is a systemic disease that contributes to the death of 500,000 Americans by myocadial infarction and 150,000 Americans by stroke each year. In addition, peripheral arterial disease affects over 7 million Americans, two thirds of whom are undiagnosed. The modification of medical and lifestyle risk factors (e.g. diet, exercise, hypertension, smoking, and diabetes) and the daily administration of aspirin have been shown to save lives. However, aspirin is a relatively weak antiplatelet agent in that it interferes with one of the less significant intracellular processes that cause platelets to bind together. In this video, Drs. Hirsch, Raps, and Topol explore the role of new antiplatelet therapies in myocardial infarction, stroke, and peripheral arterial disease. Insights into... |
 |
Pulmonary Arterial Hypertension, An Issue of Clinics in Chest Medicine (The Clinics: Surgery) by H. Palevsky (Author) The issue provides a valuable, updated resource on PAH, including topics such as epidemiology; assessing response to therapy; pathology; genetics and mediators; diagnosis; standard therapies; endothelin receptor antagonists prostanoids, and nitric oxide pathway in the treatment of PAH; combination therapy and new types of agents; surgical therapies; porto-pulmonary hypertension; and pulmonary hypertension associated with respiratory diseases, left heart disease, congenital heart disease, and thromboembolic disease. This issue provides a definitive handbook on the most important topics in PAH. |
 |
Standard Therapies for Pulmonary Arterial Hypertension: Clinics in Chest Medicine by Shoaib Alam (Author) Clinics in Chest Medicine updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. This article offers 25 pages of current and comprehensive information about pulmonary arterial hypertension. |
|
PAH therapies slashed admissions and deaths.(CARDIOVASCULAR MEDICINE)(pulmonary arterial hypertension)(Report): An article from: Internal Medicine News by Bruce Jancin (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on October 1, 2009. The length of the article is 601 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: PAH therapies slashed admissions and deaths.(CARDIOVASCULAR MEDICINE)(pulmonary arterial hypertension)(Report) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: October 1, 2009 Publisher: International Medical News Group Volume: 42 Issue: 17 Page: 29(1) Article Type: Report Distributed by Gale, a part of Cengage... | |
 |
Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment by Robyn Barst (Editor) First book dedicated to this disease, previously thought to be incurable, but with the advent of new drugs, now amenable to management and a much improved prognosis for patients From the PAH Association, the leading experts in field Incorporates the latest AACP management guidelines Includes evidence-based treatment algorithms based on the recently updated ACCP Guidelines for Medical Treatment Aimed at specialists in pulmonology and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of PAH |
 |
A Clinician's Guide to Pulmonary Arterial Hypertension: Pocketbook, Second Edition by Stewart Simon (Author) A Clinician's Guide to Pulmonary Arterial Hypertension, Second Edition enhances the overall 'PAH awareness' of the wider clinical community, and outlines the need for screening, effective diagnosis and beneficial treatment. Topics include: |
| © 2009 BrightSurf.com |